Our Merck & Co., Inc. (MRK) ESG Review
|52 Week High 📈||$119.65|
|52 Week Low 📉||$86.02|
|Earnings Per Share 💵||1.23|
|Dividend Yield 🔁||2.7229145|
Merck & Co., Inc. is one of the largest pharmaceutical companies in the world, with a long history of commitment to science and innovation. The company has a strong focus on research and development, and has been a pioneer in many important medical advances, including vaccines for polio, measles, mumps, rubella, varicella (chickenpox), and hepatitis B. Merck also developed the first anti-viral drug, acyclovir, for the treatment of herpes simplex virus infections, and the first approved human papillomavirus vaccine.
Merck’s commitment to responsible business practices extends beyond its research and development work. The company has been a leader in promoting access to medicines in developing countries, and was the first pharmaceutical company to sign the United Nations Global Compact. Merck has also been recognized for its leadership in environmental sustainability, including being named to the Dow Jones Sustainability World Index for 15 consecutive years.
Merck’s ESG rating is strong, with the company receiving top marks for its disclosure and performance in several key areas. The company is rated AAA by MSCI, the highest possible rating, for its environmental and social practices. Merck is also a member of the Dow Jones Sustainability World Index, and has been recognized as one of the world’s most sustainable companies by Corporate Knights. The company’s strong ESG rating is reflective of its long-standing commitment to responsible business practices. Merck has been a leader in promoting access to medicines in developing countries, and was the first pharmaceutical company to sign the United Nations Global Compact.
Diversified global health care company with strong research & development capabilities
Leading position in the vaccine market with blockbuster products such as Gardasil 9
A strong commitment to environmental, social, and governance (ESG) issues
The company is highly dependent on patented drugs, which are subject to generic competition
Merck has been involved in several major litigation cases in recent years
MRK ESG Summary
This is a summary of Merck & Co., Inc.'s ESG scores from Sustainalytics, MSCI, and ESG Enterprise.
|ESG Rating Agency||Score or Rating|
|Company||Merck & Co., Inc.|
|Address||2000 Galloping Hill Road,, Kenilworth, USA|
Popular ESG Stocks
|Stock||Marketcap||Industry||Price||Change %||52 Week Range||Chart (24H)||EPS||Dividend Yield|
Best Buy Co., Inc.
PayPal Holdings, Inc.
|1.66T||Internet Content & Information||$130.86||1.10%||4.67||0.00%|
First Solar, Inc.
How much is Merck & Co., Inc. (MRK) stock?
The current stock price of Merck & Co., Inc. (MRK) is $102.95.
What is Merck & Co., Inc. (MRK)'s ESG Score?
Merck & Co., Inc. (MRK) has an ESG score of 64, BBB, and as rated from Sustainalytics, ESG Enterprise, and MSCI, respectively.